North Shore University Hospital Is First on Long Island to Use New Arterial Disease Treatment

 MANHASSET, NY – The North Shore-LIJ Health System announced today that North Shore University Hospital (NSUH) in Manhasset is the first on Long Island using a new, U.S. Food & Drug Administration (FDA)-approved drug-coated balloon to treat peripheral arterial disease (PAD).

 This disease involves the buildup of plaque in arteries, which can hinder the distribution of blood throughout the body.

Prior to this new drug-coated balloon, stents were the common treatment for PAD. But with stents, particularly if they are in areas such as the legs, knees and hips, twisting and bending motions can potentially break down the devices and plaque can more easily develop on them, prompting the need for more procedures, explained Mitchell Weinberg, MD, director of the peripheral vascular intervention at NSUH and Lenox Hill Hospital in Manhattan.

The Lutonix 035 Drug Coated Balloon PTA Catheter, which NSUH began using recently, includes a therapeutic dose of Paclitaxel, which can help increase blood flow and prevent plaque from forming. In the next few weeks, Lenox Hill Hospital will join other Manhattan facilities that have recently begun using this device.

 “Using this drug-coated balloon gives us another option to offer our patients and one that would potentially require fewer hospitalizations in the future,” Dr. Weinberg said. 

 For more information about this device and treatment of PAD at North Shore University Hospital, call 516-562-4100. For details about Lenox Hill Hospital’s treatment, call 212-434-2606.

Focus onHealth TV

Watch Focus onHealth, Northwell Health's TV show. It's the healthy way to stay informed!